机构

• 上海药物研究所 [66]
• 合肥物质科学研究院 [25]
• 上海生物化学与细胞... [12]
• 化学研究所 [7]
• 金属研究所 [6]
• 高能物理研究所 [6]
• 更多

采集方式

• OAI收割 [145]
• iSwitch采集 [9]

内容类型

• 期刊论文 [142]
• 会议论文 [7]
• 学位论文 [5]

发表日期

• 2023 [2]
• 2022 [11]
• 2021 [11]
• 2020 [13]
• 2019 [6]
• 2018 [14]
• 更多

学科主题

• Cell Biolo... [6]
• Oncology; ... [3]
• Biochemist... [2]
• Oncology [2]
• Biochemist... [1]
• Biochemist... [1]
• 更多

筛选

浏览/检索结果: 共154条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   Synthesis, and biological evaluation of EGFR/HER2-NAMPT conjugates for tumor treatment 期刊论文  OAI收割 MOLECULAR DIVERSITY, 2023, 页码: 20 作者:  Ding, Mengyuan;  Shen, Qianqian;  Lu, Wei;  Zhu, Shulei   |  收藏  |  浏览/下载：62/0  |  提交时间：2023/10/17 EGFR  HER2  NAMPT  Resistance  Selectivity  Molecular docking   Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162 作者:  Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang   |  收藏  |  浏览/下载：80/0  |  提交时间：2023/04/10 fourth-generation EGFR inhibitor  EGFRC797S mutation  NSCLC  drug resistance  small molecular inhibitor   Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61 作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong   |  收藏  |  浏览/下载：74/0  |  提交时间：2022/12/22 gefitinib  CD28H  NSCLC  EGFR mutation   The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan   |  收藏  |  浏览/下载：88/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   A homogalacturonan from Lonicera japonica Thunb. disrupts angiogenesis via epidermal growth factor receptor and Delta-like 4 associated signaling 期刊论文  OAI收割 GLYCOCONJUGATE JOURNAL, 2022, 页码: 11 作者:  Liao, Wenfeng;  Hu, Xiaodong;  Du, Zhenyun;  Wang, Peipei   |  收藏  |  浏览/下载：75/0  |  提交时间：2022/12/13 Homogalacturonan  Angiogenesis  Lonicera japonica  EGFR/Raf/MEK/ERK signaling cascade  Dll4/Notch1 signaling   Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFR(del19/T790M/C797S) and EGFR(L858R/T790M/C797S)) 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 卷号: 72, 页码: 11 作者:  Fang, Haotian;  Wu, Yingming;  Xiao, Qitao;  He, Dongbo;  Zhou, Tongrui   |  收藏  |  浏览/下载：73/0  |  提交时间：2022/08/16 Non-small cell lung cancer  EGFR  Triple mutations  C797S  EGFR-TKIs   A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S.   |  收藏  |  浏览/下载：73/0  |  提交时间：2022/12/23 third-generation EGFR-TKI  befotertinib  T790M   High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Fan, Y.   |  收藏  |  浏览/下载：70/0  |  提交时间：2022/12/23 NSCLC  EGFR TKI  Brain Metastases   Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文  OAI收割 BMC CANCER, 2022, 卷号: 22 作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/12/23 Clinical and molecular features  Efficacy and outcome  EGFR T790M mutation  Non-small-cell lung cancer  Osimertinib